Shares of ResMed (RMD) and Inspire Medical Systems (INSP) fell Monday as the companies behind products to treat sleep apnea faced a new threat from weight-loss drugs.
ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Investors interested in Medical - Products stocks are likely familiar with ResMed (RMD) and Insulet (PODD). But which of these two companies is the best option for those looking for undervalued stocks?
ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Investors looking for stocks in the Medical - Products sector might want to consider either ResMed (RMD) or LeMaitre Vascular (LMAT). But which of these two companies is the best option for those looking for undervalued stocks?
The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Robust Mask and Device sales bode well for ResMed. Meanwhile, the increasing debt burden adds to the worry.
ResMed (RMD) possesses solid growth attributes, which could help it handily outperform the market.